pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$MDGLMADRIGAL PHARMACEUTICALS, INC.

$MDGL431.00-2.12%
West Conshohocken, PA, USupdated 19d ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
2
marketed
1
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0

Pipeline(2)

pipeline depth2 products
Marketed: 1Unknown: 1
1Marketed1Unknown
Marketed
resmetirom
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
drug
REZDIFFRA
1 INDICATIONS AND USAGE REZDIFFRA is indicated in conjunc…
Thyroid hormone receptor beta

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase4Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosisrecruitingn=150
  • phase1Resmetirom in Patients With MASH and HFpEFrecruitingn=90
  • phase2Study of Resmetirom in Children and Adolescents With MASHrecruitingn=61
  • phase3A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)active not recruitingn=845
  • phase2Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASHrecruitingn=120
  • —Rezdiffra Pregnancy and Lactation Registryrecruitingn=10
  • phase2Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)completedn=125
  • phase2Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)completedn=116
🐶 Hiring Signal
No open roles indexed yet — view MADRIGAL PHARMACEUTICALS, INC. jobs →

News

  • Rasonque sales drive RevMed's stock; whistleblower sues Madrigal over MASH
    Plus news about Rezera, ANI Pharmaceuticals, Cloudbreak Pharma and Anaheim Bio. RevMed’s stock jumps on early Rasonque sales: The RAS drug developer reported sales of its pancreatic cancer therapy…
    endpoints · 11d ago
  • A treatment revolution is underway in MASH
    To build on the momentum in MASH, we—at Madrigal Pharmaceuticals and the industry more widely—must further expand approaches to diagnosis, monitoring and individualized treatment to help more patie…
    biospace · 12d ago
  • STAT+: Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug
    A top former executive at Madrigal Pharmaceuticals has filed a lawsuit in federal court alleging a coverup of drug safety issues.
    stat · 12d ago
  • Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
    Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to investors, some say.
    biopharma_dive · 6mo ago
identifiers
ticker
$MDGL
SEC CIK
0001157601
country
US
source
sec_tickers
mentioned in
4news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 36m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?